tiprankstipranks
Trending News
More News >
PharmAla Biotech Holdings, Inc. (TSE:MDMA)
:MDMA
Canadian Market
Advertisement

PharmAla Biotech Holdings, Inc. (MDMA) Revenue

Compare
61 Followers

PharmAla Biotech Holdings, Inc. Revenue

PharmAla Biotech Holdings, Inc. had a revenue of 135.17K in the quarter ending May 31, 2025, with -7.20%. This bring the company's revenue in the last twelve months to 338.12K, Increased -1.36%. In the fiscal year ending Dec 31, 2024, PharmAla Biotech Holdings, Inc. had annual revenue of 1.04M with 94.60% growth.
Revenue (ttm)
338.12K
Revenue Growth
-72.51%
P/S Ratio
11.74
Revenue/Employee
Employees
Market Cap
C$12.15M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
1.04M503.29K+194.60%
Dec 31, 2023
532.00K453.93K+681.45%
Dec 31, 2022
78.07K-7,807,000.00%
Dec 31, 2021
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis